Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Efficacy, Safety, and Quality of Life (QOL) in Patients With Chronic Idiopathic Urticaria Dosed With AERIUS Tablets (Desloratadine 5 mg, 10 mg, or 20 mg Once Daily)

NCT00536380 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00536380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00536380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Efficacy, Safety, and Quality of Life (QOL) in Patients With Chronic Idiopathic Urticaria Dosed With AERIUS Tablets (Desloratadine 5 mg, 10 mg, or 20 mg Once Daily)
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2007
Completion date
April 30, 2009
Enrollment
314 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic idiopathic urticaria